蘇志教授、劉紅科教授課題組在RSC ADVANCES發(fā)表研究論文
Unveiling the anti-cancer mechanism for half-sandwich and cyclometalated Ir(iii)-based complexes with functionalized alpha-lipoic acid
Wang, MM (Wang, Meng-Meng)[ 1 ] ; Xue, XL (Xue, Xu-Ling)[ 1 ] ; Sheng, XX (Sheng, Xi-Xi)[ 1 ] ; Su, Y (Su, Yan)[ 1 ] ; Kong, YQ (Kong, Ya-Qiong)[ 1 ] ; Qian, Y (Qian, Yong)[ 1 ] ; Bao, JC (Bao, Jian-Chun)[ 1 ] ; Su, Z (Su, Zhi)[ 1 ]*（蘇志） ; Liu, HK (Liu, Hong-Ke)[ 1 ]*（劉紅科）
[ 1 ] Nanjing Normal Univ, Coll Chem & Mat Sci, Jiangsu Collaborat Innovat Ctr Biomed Funct Mat, Nanjing 210023, Peoples R China
RSC ADVANCES，202002,10(9),5392-5398
Alpha lipoic acid (LA) is a natural compound and coenzyme with sufficient safety information for serving as a promising anticancer agent. To further clarify the mechanism of action (MoA), two Ir(iii) complexes with the functionalized alpha-lipoic acid ((NN)-N-boolean AND-LA, (NN)-N-boolean AND, 2,2-bipyridine derivative), namely Ir1 and Ir2, were synthesized, where Ir1 possessed a half-sandwich structure with the formula [Ir(Cp*)((NN)-N-boolean AND-LA)Cl]PF6 (Cp* = 1,2,3,4,5-pentamethyl-cyclopentadiene) and Ir2 possessed the cyclometalated structure with the formula [Ir((CN)-N-boolean AND)(2)((NN)-N-boolean AND-LA)]PF6 ((CN)-N-boolean AND = 2-phenylpyridine). Even though both complexes were constructed based on the same (NN)-N-boolean AND-LA ligand, Ir1 showed no cytotoxicity (IC50 > 200 mu M), which was due to its low lipophilicity for hard penetration into the cancer cells, easy hydrolysis, and reaction with GSH. Ir2 exhibited excellent cytotoxicity (IC50 = 3.43-6.74 mu M) toward diverse cancer cell lines in vitro and a promising ability to overcome the cisplatin-resistance in A549R cells. The anticancer mechanism of Ir2 in A549 cells was investigated in detail, and it was found it could localize and accumulate in the lysosomes of A549 cells, induce ROS, arrest the cycle at G(0)/G(1), and lead to cell death by autophagy. Comparison with Ir-NH2 ([Ir((CN)-N-boolean AND)(2)((NN)-N-boolean AND-NH2)]PF6) demonstrated that introduction of the LA ligand to Ir2 could highly enhance the cytotoxicity and help to overcome the cisplatin-resistance. This study of the half-sandwich and cyclometalated Ir(iii)-based anticancer agents highlighted the different MoAs toward cancer cells and provided new insights for understanding their structure-property relationships.
文章鏈接：
https://pubs.rsc.org/en/content/articlelanding/2020/RA/C9RA10357K#!divAbstract
版權(quán)與免責(zé)聲明：本網(wǎng)頁的內(nèi)容由收集互聯(lián)網(wǎng)上公開發(fā)布的信息整理獲得。目的在于傳遞信息及分享，并不意味著贊同其觀點或證實其真實性，也不構(gòu)成其他建議。僅提供交流平臺，不為其版權(quán)負(fù)責(zé)。如涉及侵權(quán)，請聯(lián)系我們及時修改或刪除。郵箱：sales@allpeptide.com